We are live on ! Find out more
HCM

Highlander Capital Management Portfolio holdings

AUM $292M
1-Year Est. Return 22.24%
This Fund
S&P 500
This Quarter Est. Return
+20.79%
1 Year Est. Return
+22.24%
3 Year Est. Return
+34.41%
5 Year Est. Return
+97.97%
10 Year Est. Return
+157.99%
AUM
$159M
AUM Growth
+$19.5M
Cap. Flow
-$22M
Cap. Flow %
-13.87%
Top 10 Hldgs %
30.41%
Holding
660
New
12
Increased
62
Reduced
55
Closed
65

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$514K
2
PFE icon
Pfizer
PFE
+$474K
3
CVX icon
Chevron
CVX
+$342K
4
HD icon
Home Depot
HD
+$315K
5
PSLV icon
Sprott Physical Silver Trust
PSLV
+$284K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$577K
2
UAL icon
United Airlines
UAL
+$443K
3
NVDA icon
NVIDIA
NVDA
+$388K
4
UMH
UMH Properties
UMH
+$362K
5
CC icon
Chemours
CC
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 19.9%
2 Miscellaneous 18.57%
3 Technology 12.71%
4 Financials 12.11%
5 Consumer Discretionary 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMH.PRE
176
DELISTED
American Homes 4 Rent 6.35% Series E Cumulative Redeemable Perpetual Preferred Shares of Beneficial
AMH.PRE
$62K 0.04%
2,500
+500
+25% +$12.6K
GDXJ icon
177
VanEck Junior Gold Miners ETF
GDXJ
$8.97B
$59K 0.04%
1,188
+500
+73% +$21.2K
LLY icon
178
Eli Lilly
LLY
$1.03T
$59K 0.04%
357
– –
CG icon
179
Carlyle Group
CG
$14.8B
$56K 0.04%
2,000
-800
-29% -$20.5K
WYNN icon
180
Wynn Resorts
WYNN
$8.98B
$56K 0.04%
750
– –
PDM
181
Piedmont Realty Trust
PDM
$1.17B
$54K 0.03%
3,239
– –
NSC icon
182
Norfolk Southern
NSC
$72B
$53K 0.03%
300
– –
PJP icon
183
Invesco Pharmaceuticals ETF
PJP
$541M
$52K 0.03%
+800
New +$49.7K
CLX icon
184
Clorox
CLX
$10.7B
$50K 0.03%
230
– –
QQQ icon
185
Invesco QQQ Trust
QQQ
$476B
$50K 0.03%
200
– –
VLYPP
186
Valley National Bancorp 6.25% Series A Preferred Stock
VLYPP
$116M
$50K 0.03%
2,000
– –
TIP icon
187
iShares TIPS Bond ETF
TIP
$14.7B
$49K 0.03%
395
+1
+0.3% +$122
TFC icon
188
Truist Financial
TFC
$61.8B
$48K 0.03%
1,280
– –
GILD icon
189
Gilead Sciences
GILD
$179B
$47K 0.03%
610
+50
+9% +$3.83K
SRE icon
190
Sempra
SRE
$54B
$47K 0.03%
800
– –
RDS.A
191
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$47K 0.03%
1,450
-7,182
-83% -$246K
MKL icon
192
Markel Group
MKL
$22.2B
$46K 0.03%
50
– –
DBA icon
193
Invesco DB Agriculture Fund
DBA
$1.25B
$45K 0.03%
3,350
+600
+22% +$8.16K
WY icon
194
Weyerhaeuser
WY
$16B
$45K 0.03%
2,000
– –
GD icon
195
General Dynamics
GD
$96.1B
$44K 0.03%
296
– –
ITB icon
196
iShares US Home Construction ETF
ITB
$2.13B
$44K 0.03%
1,000
– –
RF icon
197
Regions Financial
RF
$25.7B
$44K 0.03%
4,000
-250
-6% -$2.66K
FCRD
198
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$44K 0.03%
13,550
-600
-4% -$1.78K
ACN icon
199
Accenture
ACN
$119B
$43K 0.03%
200
– –
F icon
200
Ford
F
$55.1B
$43K 0.03%
7,051
-500
-7% -$2.77K
6 7
8
9 10

Similar funds

MFF
Mango Five Family Reno, Nevada $301M AUM
SFG
Summit Financial Group Moorefield, West Virginia $281M AUM 21.6% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
FW
FirstPurpose Wealth Orem, Utah $276M AUM 19.3% 1-Year Est. Return
CSC
Cook Street Consulting Greenwood Village, Colorado $326M AUM 4.42% 1-Year Est. Return
ORPU
Orion Resource Partners (USA) New York $333M AUM 13.37% 1-Year Est. Return
APWM
Atlas Private Wealth Management Albany, New York $238M AUM 17.48% 1-Year Est. Return

Highlander Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Highlander Capital Management held 660 positions worth $159M, up 14% from $139M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Highlander Capital Management withdrew a net $22M in Q2 2020, closing 65 positions and reducing 55 holdings. Its most notable exit was Humana, an estimated $314K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Highlander Capital Management opened a new position in Invesco Pharmaceuticals ETF worth $52K.

  • Highlander Capital Management's largest Q2 2020 buy was Invesco Pharmaceuticals ETF: 800 shares worth $52K.
  • Highlander Capital Management added most to AT&T in Q2 2020, an estimated $514K increase.
  • Highlander Capital Management's biggest Q2 2020 reduction was CVS Health, cutting an estimated $577K.
  • Highlander Capital Management fully exited Humana in Q2 2020, selling an estimated $314K.
  • Highlander Capital Management's ten largest holdings make up 30% of its $159M portfolio in Q2 2020.
  • Highlander Capital Management opened 12 new positions and closed 65 in Q2 2020.
  • Highlander Capital Management's portfolio value rose 14% quarter-over-quarter to $159M.

Based on Highlander Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.